Simplex Trading
BLCM

Simplex Trading’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Simplex Trading’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10
Closed -$7K – 8753
2020
Q2 		$7K Sell
10
-4
-29% -$27 ﹤0.01% 6859
2020
Q1 		$6K Buy
14
+6
+75% +$64 ﹤0.01% 6790
2019
Q4 		$10K Buy
8
+1
+14% +$9 ﹤0.01% 6405
2019
Q3 		$7K Buy
7
+3
+75% +$39 ﹤0.01% 6476
2019
Q2 		$6K Sell
4
-4
-50% -$108 ﹤0.01% 6405
2019
Q1 		$27K Buy
8
+6
+300% +$201 ﹤0.01% 5509
2018
Q4 		$4K Sell
2
-2
-50% -$89 ﹤0.01% 6360
2018
Q3 		$22K Sell
4
-7
-64% -$474 ﹤0.01% 5894
2018
Q2 		$77K Sell
11
-5
-31% -$390 ﹤0.01% 4592
2018
Q1 		$34K Hold
16
– – ﹤0.01% 2826
2017
Q4 		$61K Buy
16
+1
+7% +$98 ﹤0.01% 2254
2017
Q3 		$43K Sell
15
-9
-38% -$947 ﹤0.01% 2453
2017
Q2 		$21K Buy
24
+7
+41% +$869 ﹤0.01% 3273
2017
Q1 		$10K Buy
17
+7
+70% +$917 ﹤0.01% 4001
2016
Q4 		$60K Sell
10
-42
-81% -$7.46K ﹤0.01% 1988
2016
Q3 		$104K Buy
52
+38
+271% +$6.54K 0.01% 1504
2016
Q2 		$24K Buy
14
+12
+600% +$1.34K ﹤0.01% 2749
2016
Q1 		$1K Sell
2
-9
-82% -$980 ﹤0.01% 5292
2015
Q4 		$20K Buy
11
+5
+83% +$894 ﹤0.01% 2704
2015
Q3 		$6K Buy
+6
New +$1.1K ﹤0.01% 3901

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading's BLCM Position: Q3 2019 in Review

Simplex Trading sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2019, closing a stake of 4,103 shares — an estimated $53.6K sold.

Simplex Trading first reported a position in BLCM in Q4 2015 and held it in 14 quarters. The position peaked at $342K in Q3 2016. 67 funds tracked by Wall St. Rank hold BLCM as of Q3 2019.

  • Simplex Trading reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Simplex Trading sold 4,103 Bellicum Pharmaceuticals, Inc. shares in Q3 2019, an estimated $53.6K.
  • Simplex Trading first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
  • Simplex Trading's Bellicum Pharmaceuticals, Inc. position peaked at $342K in Q3 2016.
  • 67 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.